{"preliminary_commentary":{"by_channel":{"x_thread":12},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02960087\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"name":"PR19","nct_id":"NCT02960087","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=pr19-nct02960087. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Low Dose Rate (LDR) brachytherapy with I-125 to a total dose of 144 Gy","label":"Arm 1 LDR","type":"ACTIVE_COMPARATOR"},{"description":"High Dose Rate brachytherapy: 27 Gy in 2 fractions","label":"Arm 3 HDR","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2029-10-30","type":"ESTIMATED"},"conditions":["Prostate Carcinoma"],"enrollment":{"count":334,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Low dose rate brachytherapy","otherNames":[],"type":"RADIATION"},{"name":"High dose rate brachytherapy","otherNames":[],"type":"RADIATION"}],"last_update":"2026-04-22","lead_sponsor":"Canadian Cancer Trials Group","official_title":"A Randomized Phase II Trial Evaluating High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer","overall_status":"ACTIVE_NOT_RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2029-04-30","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Efficacy of HDR and LDR brachytherapy on prostate cancer control as defined by 48 month PSA values","timeFrame":"48 months"}],"references":[],"start_date":{"date":"2017-03-06","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer","url":"https://clinicaltrials.gov/study/NCT02960087"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/pr19-nct02960087"}